Thea van Asselt

Guest Editor, Global & Regional Health Technology Assessment

Thea van Asselt started doing research in the field of Health Technology Assessment (HTA) in 1998 at the University Medical Center Groningen (UMCG), after obtaining an MSc degree in Economics at Groningen University in 1996.

From 2000-2014 she worked at the department of Clinical Epidemiology & Medical Technology Assessment (KEMTA) of the Maastricht UMC+. Her PhD thesis (2008, Maastricht University) was on the economic aspects of treatment for Borderline Personality Disorder.

Since March 2014, she is back at the UMCG as a health economist. Her expertise is predominantly in performing both trial-based and model-based economic evaluations, covering various clinical areas such as mental health, pregnancy complications, and cardiology. During her time in Maastricht, from 2011 onwards, she was a member of an evidence review group conducting assessments of new pharmaceuticals and technologies for the National Institute of Clinical Excellence (NICE) in the UK.

She is the co-coordinator of the course ‘economic evaluation in healthcare’ in the MSc BA Health of the faculty of Economics and Business at the University of Groningen. She is also a member of the 'Rational Pharmacotherapy' committees of the Netherlands Organisation for Health Research and Development (ZonMw).

At current, she is involved in a European (IMI) project on combating antimicrobial resistance by optimising antibiotic use through diagnostics.

As Guest Editor she took an active role in the completion of the special issue dedicated to "Mental Health Economics: the Netherlands experience".